[일:] 2025년 04월 14일

Recent discussions between BlackRock and the SEC about Bitcoin and Ethereum ETFs propose a shift to physical redemptions, enhancing liquidity and reducing costs. Nasdaq and NYSE are also considering 24-hour trading to meet global investor demand. Meanwhile, the Feixiaohao Global Tour highlighted AI’s role in cryptocurrency trading, suggesting these trends could transform financial markets and improve investor experiences.

Recent developments in the pharmaceutical sector include Pfizer and GSK’s legal dispute over RSV vaccine patents, which has been dismissed. China aims to boost foreign investment amid U.S. tensions, while Medicare prepares for drug price negotiations. Pfizer faces a $60 million settlement related to Biohaven’s alleged kickbacks. Market indices declined due to profit-taking and inflation concerns, signaling challenges ahead for the industry. Investors should monitor ongoing regulatory and ethical issues that may impact Pfizer and the larger healthcare market.

Nubank plans to expand beyond Latin America, aiming for a U.S. market entry. Despite a strong 87% profit increase, its shares fell 6% due to missed revenue expectations. Meanwhile, Shift4 Payments targets over 25% revenue growth in 2024, capitalizing on its payment services for the hospitality sector. Both companies face challenges amid changing interest rates and competition.

A study published in the New England Journal of Medicine reveals that individuals aged 50 and older without heart disease risk factors may live over ten years longer than those with such risks. Maintaining heart health through lifestyle changes can enhance both longevity and quality of life, emphasizing the importance of prevention and proactive health measures.